Ver mas grande
BCL10 antibody
FT-FNab00835
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | BCL10 |
| Research Area | Immunology, Signal Transduction |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | B-cell CLL/lymphoma 10 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | B-cell lymphoma/leukemia 10|B-cell CLL/lymphoma 10 (Bcl-10)|CARD-containing molecule enhancing NF-kappa-B|CARD-like apoptotic protein (hCLAP)|CED-3/ICH-1 prodomain homologous E10-like regulator (CIPER)|Cellular homolog of vCARMEN (cCARMEN)|Cellular-E10 (c |
| Host | Rabbit |
| UniProt ID | O95999 |
| Gene ID | 8915 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 32kd |
| Background | Involved in adaptive immune response(PubMed:25365219). Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK. May be an adapter protein between upstream TNFR1-TRADD-RIP complex and the downstream NIK-IKK-IKAP complex. I |
Más información
BCL10 antibody